NCT03455270 2022-12-15
G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer
G1 Therapeutics, Inc.
Phase 1 Completed
Clinical Trials
4 trialsNCT00680667 2017-11-29
Clinical Trial of Trametes Versicolor in Women With Breast Cancer
Masonic Cancer Center, University of Minnesota
Phase 1 Completed
NCT00027807 2016-02-17
Biological Therapy in Treating Women With Stage IV Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT00749437 2012-06-14
Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer
Rutgers, The State University of New Jersey
Phase 1 Completed